Metraipolis › archive › dc_0e7ec4cf75bc
Molecular and Antiangiogenic Effects of Paclitaxel-Loaded Nanoparticles: Influence of the Nanocarrier Type — Europe PMC PMID:41790974
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41790974
- DOI
- 10.1021/acs.molpharmaceut.5c01740
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T02:49:27.104Z
- SHA-256 of the archived text
534d3e5079bfa79c79c07e38a7f62d187cb4a024593327493061a3c8701cde33- Stable URL of this page
https://metraipolis.com/documento/dc_0e7ec4cf75bc
How to cite
Molecular and Antiangiogenic Effects of Paclitaxel-Loaded Nanoparticles: Influence of the Nanocarrier Type — Europe PMC PMID:41790974 — Europe PMC (en), https://europepmc.org/article/MED/41790974 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e7ec4cf75bc (Metraipolis archive dc_0e7ec4cf75bc, sha256 534d3e5079bfa79c79c07e38a7f62d187cb4a024593327493061a3c8701cde33)
BibTeX
@misc{dc0e7ec4cf75bc,
title = {Molecular and Antiangiogenic Effects of Paclitaxel-Loaded Nanoparticles: Influence of the Nanocarrier Type — Europe PMC PMID:41790974},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41790974},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e7ec4cf75bc; sha256 534d3e5079bfa79c79c07e38a7f62d187cb4a024593327493061a3c8701cde33},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41790974. Agents can read the archived copy with the MCP tool read_document.